GlassScriptPhysician profile
Hector J Trujillo
NPI 1912996331
$2,356.75
in general payments reported to CMS, 2019-2025
18 companies · $247 in 2025
The $247 reported for 2025 was more than what 80% of Pediatrics providers received nationally (typical 2025 total: $96.93).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $639 · 2020: $285 · 2021: $366 · 2022: $201 · 2023: $343 · 2024: $276 · 2025: $247.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $866.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $865.87 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $449.37 | 2019-2025 | Bexsero |
| Pfizer INC. | $390.79 | 2019-2025 | |
| Sanofi Pasteur INC. | $184.23 | 2019-2025 | |
| Ironshore Pharmaceuticals INC. | $172.60 | 2019-2023 | Jornay Pm |
| Abbvie INC. | $154.41 | 2019-2021 | |
| Tris Pharma INC | $146.35 | 2019-2025 | Dyanavel Xr |
| Corium, LLC | $143.50 | 2024-2025 | Azstarys |
| Cranial Technologies, INC | $141.93 | 2019-2024 | Doc Band |
| Verrica Pharmaceuticals INC. | $124.99 | 2023 | Ycanth |
| Merck Sharp & Dohme LLC | $119.71 | 2019-2025 | Vaxneuvance, Gardasil 9, M-M-R II |
| Takeda Pharmaceuticals U.S.A., INC. | $73.41 | 2021-2022 | |
| Otsuka America Pharmaceutical, INC. | $58.40 | 2019 | |
| Alk-Abello, INC | $52.79 | 2021-2025 | Neffy |
| Teva Pharmaceuticals USA, INC. | $44.84 | 2019 | |
| Ultragenyx Pharmaceutical INC. | $40.00 | 2021-2022 |
Show all 18 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kaleo, INC. | $23.18 | 2020 | |
| Tempus Ai, INC | $22.20 | 2024 | |
| Phadia US INC. | $14.05 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Hector Trujillo listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.